CNCT19 not checked

Juventas Cell Therapy Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
3 active
5 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Dose: 0.5 x 10\^8 CNCT19 Cell Injection via intravenous infusion. Drug: Fludarabine Drug: Cyclophosphamide”In the company’s words, NCT04684147 on ClinicalTrials.gov
Tested for
Relapsed or Refractory Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, B-cell Acute Lymphoblastic Leukemia
Main trialPhase 2
“The study is a Phase II, single-arm, open-label, single-dose clinical trial, and its primary objective is to evaluate the efficacy and safety of CNCT19 Cell Injection in the treatment of CD19 positive Relapsed or Refractory acute lymphoblastic leukemia.”In the company’s words, NCT04684147 on ClinicalTrials.gov

Other drugs for Relapsed or Refractory Acute Lymphoblastic Leukemia

All 266 drugs for Relapsed or Refractory Acute Lymphoblastic Leukemia

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials5

TrialPhaseCompletesWhat it tests
Phase 2Recruiting 22 Sep 2022 Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 2Recruiting 30 Mar 2024 Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
Phase 1/2Recruiting 30 May 2025 A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)
Phase 1Completed 1 Dec 2020 A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 1Completed 1 Jan 2021 A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Diffuse Non-Hodgkin Lymphoma
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow CNCT19

Following is part of Solo: you see every change to CNCT19 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in